Tadalafil
Tadalafil is a pharmaceutical drug with 138 clinical trials. Currently 6 active trials ongoing. Historical success rate of 88.8%.
Success Metrics
Based on 103 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
33
Mid Stage
73
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.8%
103 of 120 finished
14.2%
17 ended early
6
trials recruiting
138
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Clinical Trials (138)
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
PDE5 Inhibitor for Alzheimer's Disease
Comparison of Sequential to Initial Combination Therapy in PAH
Vasodilator and Exercise Study for DMD (VASO-REx)
Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck
A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Tadalafil as Adjuvant Therapy for DMD
Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension
A Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study
Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
The Effects of a Nitrate Supplementation on Erectile Function
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 138